Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.91
-0.25 (-0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Axsome Therapeutics to Present at Three Upcoming Investor Conferences
September 05, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The Top Healthcare Stocks to Buy With $100
August 30, 2023
Both stocks have outperformed the broader market in the last 12 months.
Via
The Motley Fool
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
August 24, 2023
Today's market loser could be tomorrow's market winner.
Via
The Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
August 19, 2023
There's no guarantee that any stock will deliver 2 times returns. But the chances for these stocks look pretty good.
Via
The Motley Fool
Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
August 15, 2023
A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.
Via
Investor's Business Daily
Analyst Ratings for Axsome Therapeutics
August 11, 2023
Via
Benzinga
Expert Ratings for Axsome Therapeutics
July 17, 2023
Via
Benzinga
Why Shares of Axsome Therapeutics Fell Wednesday
June 28, 2023
The biopharmaceutical company announced a $225 million stock sale.
Via
The Motley Fool
3 Explosive Stocks to Buy Right Now
August 10, 2023
These stocks are poised to pop in the not-too-distant future.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
August 08, 2023
Piper Sandler raised the price target for Chegg, Inc. (NYSE: CHGG) from $11 to $13. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Chegg shares rose 19.9% to $12.03 in pre-market...
Via
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
June 28, 2023
These companies are coming into their own.
Via
The Motley Fool
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q2 sales of $46.7 million, beating the consensus of $40.19 million.
Via
Benzinga
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
August 07, 2023
AXSM earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
3 Fantastic Growth Stocks to Buy in August
August 05, 2023
These stocks could be poised to soar.
Via
The Motley Fool
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
August 03, 2023
There's lots of upside potential for these drugmakers.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 20, 2023
These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector.
Via
InvestorPlace
Baidu To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Monday
July 17, 2023
Keybanc boosted the price target for Camping World Holdings, Inc. (NYSE: CWH) from $28 to $36. Keybanc analyst Noah Zatzkin maintained an Overweight rating. Camping World shares rose 1.4% to $32.04 in...
Via
Benzinga
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
July 13, 2023
There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good.
Via
The Motley Fool
Axsome Therapeutics to Report Second Quarter 2023 Financial Results on August 7
July 12, 2023
Axsome to host conference call and webcast on Monday, Aug. 7, 2023, at 8:00 a.m. Eastern Time
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults
July 07, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
5 Top Stocks for July
July 01, 2023
This basket of stocks has it all, including growth, dividend income, and value.
Via
The Motley Fool
Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
June 30, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 28, 2023
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Via
Benzinga
Why Is Xponential Fitness (XPOF) Stock Up 19% Today?
June 28, 2023
Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research.
Via
InvestorPlace
Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today?
June 28, 2023
Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering.
Via
InvestorPlace
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
June 28, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock
June 28, 2023
Markets could have a tough time building on gains from Tuesday.
Via
The Motley Fool
Axsome Therapeutics Stock Is Moving Lower: What's Going On?
June 28, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.